Pave The Way For Evidence-informed Health Care And Policy-making

Transcription

Pave the Way for Evidence-informedHealth Care and Policy-makingSecond AnnouncementThe First Cochrane Hong Kong Symposium23-24 May 2019Post-symposium Workshops27-28 May 2019OrganiserCochrane Hong Kong, The Nethersole School of Nursing,Faculty of Medicine,The Chinese University of Hong Kong, Hong KongSponsor

Welcome MessageSymposium AimThe symposium aims to provide an internationalmultidisciplinary platform for discussion and debate amonghealth care providers, policy makers, academics, andresearchers on contemporary strategies and issues inevidence-informed health care and policy formulation.Symposium ObjectivesTo facilitate opportunities for networking, collaborationand exchange of ideas with internationally renownedleaders and experts in evidence-based practice andeducation.To debate and identify gaps and priority areas forevaluating research- and practice-based innovationsin optimising multidisciplinary and complex health care.It is my great pleasure to invite you to the First Cochrane Hong Kong Symposium which will be organised by CochraneHong Kong at the Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong on 23-24 and27-28 May 2019.Over the past two decades, Cochrane has significantly contributed to the promotion of evidence-informed health caredecision-making through producing high quality and accessible systematic reviews and other synthesised researchevidence. Cochrane evidence is internationally regarded as a powerful tool to enhance health care knowledge andpractice. With the establishment of Cochrane Hong Kong, our School is committed to working hand in hand with otherCochrane centres around the world especially those in Asia towards a shared vision for better health.This symposium, themed ‘Pave the way for evidence-informed health care and policy-making’, aims to provide aninternational multidisciplinary platform for health care providers, policy makers, academics and researchers to discusscontemporary strategies and issues in evidence-informed health care and policy formulation. It will also offer a valuableopportunity for participants to learn, network, exchange knowledge and foster relationships. Through the symposium,participants are expected to identify gaps and priority areas for evaluating innovations, examine review methodologies,and share new strategies and challenges in advancing the use of reliable research evidence to inform practice and policymaking, and to address some of the world’s most-concerned diseases and health conditions.During the symposium, internationally renowned Cochrane experts and health care scholars and researchers will beinvited as keynote or plenary speakers. Also, there will be concurrent sessions to look into a wide range of theme-relatedtopics, helping participants to make informed decisions for enhanced quality of care and health outcomes. After thesymposium, a series of professional workshops will be arranged to enrich participants’ knowledge and competencies inunderstanding and using systematic reviews in particular Cochrane Reviews.Hong Kong is a unique and vibrant city bringing together the richness of Chinese and western cultures in a spectacularsetting. Apart from attending the symposium, participants may also take this opportunity to explore the beauty andattractions of our city, which I believe will be an exciting and unforgettable experience.To share new initiatives, strategies and challenges inachieving improved global health protection, betterpatient outcomes, and greater satisfaction amonghealth care workers.Language of SymposiumThe official language of the symposium is English.Continuing NursingEducation (CNE)AccreditationParticipants can earn up to 13 Nursing Council of HongKong CNE points for attending the 2-day symposium;and up to 12 Nursing Council of Hong Kong CNE pointsfor attending the 2-day post-symposium workshops.Call for AbstractAbstracts for oral/ poster presentations relating to anyof the following symposium sub-themes are invited:1.Knowledge synthesisTo examine and discuss the role of systematic reviewsin supporting health care and service delivery.2.Knowledge translation and communication ofevidenceTo explore and discuss challenges and opportunitiesin the new era for health care innovation andevidence-informed health care and policy formulation.3.Evidence-informed health care4.Evidence-based health policy and leadershipin health care5.Review methodologies and advanced researchmethodologies6.Contemporary issues and challengesachieving collaboration in best practiceWorkshop ObjectivesTo enable participants to understand and interpretsystematic reviews and use Cochrane Reviews.To equip participants with knowledge and skills inconducting systematic reviews.inLate breaking abstract submission is NOW OPEN! Take advantage of this opportunity to share your abstract with international colleagues, healthcare providers andresearchers! Late Breaking Abstract Submission Deadline: 26 April 2019We look forward to seeing you at the symposium in May 2019.Sek Ying CHAIRDirector and ProfessorThe Nethersole School of NursingFaculty of MedicineThe Chinese University of Hong Kong02 The First Cochrane Hong Kong SymposiumThe First Cochrane Hong Kong Symposium 03

Opening SpeakerImportant DatesEventDateAbstract submission opens1 December 2018Registration opens15 January 2019Deadline for abstract submission15 March 2019Notification of abstract acceptance22 March 2019Deadline for early bird registration29 March 2019Deadline for late breaking abstract submission26 April 2019Online registration closes (Symposium and Workshop)22 May 2019 (On-site registration available)Symposium23-24 May 2019Opening ceremony23 May 2019Symposium dinner24 May 2019Post-symposium workshops27-28 May 2019Professor Martin J. BURTONBest Presentation AwardsMr. Mark G. WILSONThere will be four categories of awards:Best student oralpresentation awardsBest student posterpresentation awardsFive highest rated abstracts in each category will be shortlistedto compete for the awards.Symposium VenueYasumoto International Academic ParkThe Chinese University of Hong KongShatin, N.T., Hong KongChief Executive Officer, CochraneBest oralpresentation awardsBest posterpresentation awardsMr. Mark Wilson started working as Cochrane’s new ChiefExecutive Officer in November 2012. He has extensiveleadership experience at the highest levels in internationalhumanitarian and development organisations, includingthe International Federation of Red Cross and Red CrescentSocieties, where he was Chef de Cabinet, Senior Advisorto the Secretary General and the organisation’s Head ofPlanning. Previously he had been Head of Delegation inMozambique; managed the Federation’s humanitarianoperations in former Yugoslavia from 1996 to 2000; andin charge of the Federation’s Appeals & Reports for Africaand Europe from 1994 to 1996.From 2004 to 2012, Mr. Wilson was Executive Director ofPanos London, and Chair of the worldwide Panos Networkof Institutes which he helped to establish. Panos aimsto ensure information and communication is effectivelyused to foster public debate, pluralism and democracyamongst poor and marginalised communities around theworld.He is a member of the Royal Institute of InternationalAffairs and the International Institute for Strategic Studies,and a Fellow of the Chartered Management Institute inthe UK. He holds Master’s degrees from Universities inthe UK and Canada in International Politics; Soviet andEast European Studies; Journalism; and Management.As a former journalist in London and Hong Kong,and Communications Director of the Swiss-basedBusiness Council for Sustainable Development, he is anexperienced commentator on international economics,business and politics.04 The First Cochrane Hong Kong SymposiumKeynote SpeakersDirector, Cochrane UK, United KingdomCo-Chair, Cochrane BoardProfessor of Otolaryngology,Nuffield Department of Surgical Sciences,University of OxfordHonorary Consultant Otolaryngologist,Oxford University Hospitals NHS Foundation TrustProfessor Martin Burton is Director of Cochrane UK,the unit responsible for supporting the activities ofCochrane contributors in the UK and Ireland, and CoChair of Cochrane’s international Governing Board. He isProfessor of Otolaryngology at the University of Oxford,an Honorary Consultant Otolaryngologist at the OxfordUniversity Hospitals NHS Foundation Trust, based atthe John Radcliffe Hospital in Oxford, and Fellow inClinical Medicine at Balliol College Oxford. He is jointCo-ordinating Editor of Cochrane ENT, the group withinCochrane responsible for ear, nose & throat disordersand head & neck cancer, which he helped to establishin 1998.He trained as a medical student at Cambridge and OxfordUniversities and did his early clinical training in Oxfordand Bristol. He was a Fulbright Scholar and undertookresearch training at the Kresge Hearing Research Instituteat the University of Michigan, US. Following a period asLecturer in Otolaryngology at the University of Melbourne,Australia, he completed his doctoral thesis on the safetyof cochlear implantation in small children. His highersurgical training was completed in London and as Fellowin Otology, Neuro-otology & Skull Base Surgery at JohnsHopkins University in Baltimore, US.The First Cochrane Hong Kong Symposium 05

Keynote SpeakersPlenary SpeakersPlenary SpeakersProfessor Sally Wai Chi CHANIncoming Pro Vice Chancellor (Singapore),University of Newcastle SingaporeProfessor Laurie BADZEKProfessor Linda P. SARNADean and Professor, School of Nursing,The University of California, Los Angeles, United StatesLulu Wolf-Hassenplug Endowed Chair in NursingProfessor Linda Sarna, Dean of the UCLA School ofNursing, is an oncology nurse with expertise in lung cancerand is a leader in nursing research and tobacco control.She was declared an 'Edge Runner', along with Dr. StellaA. Bialous, by the American Academy of Nursing for theTobacco Free Nurses initiative, which aimed to expandnursing education, leadership and research in tobaccocontrol. This was the first programme in the UnitedStates to help nurses with smoking cessation and wasrecognised as an exemplar by WHO. Professor Sarna haspartnered with nursing organisations around the worldto develop policies and programmes in this area. Shehas published extensively about the leadership role ofnurses in tobacco control education and policy, includingpapers about web-based educational interventions fornurses in Asia and Central/Eastern Europe. She led theeffort to implement the tobacco-free policy at Universityof California, Los Angeles. Professor Sarna received theLifetime Achievement Award from the Oncology NursingSociety in 2018.06 The First Cochrane Hong Kong SymposiumDean and Professor,College of Nursing, The Pennsylvania State University,Pennsylvania, United StatesProfessor Laurie Badzek, Professor and Dean of PennState’s College of Nursing is a nurse, attorney and educator,who specialises in genomics education and competency,health care ethics and law, nursing practice, and ethicaldecision making. Additionally, Professor Badzek servedas the director for nearly 20 years of the American NursesAssociation (ANA) Centre for Ethics and Human Rights,an organisation addressing complex ethical and humanrights issues confronting nurses, stepping down in 2017.A champion for improving health care through nursingpolicy, practice and education, Professor Badzek, in2001 and 2015, shepherded the revision of the ANACode of Ethics for Nurses, a document used by nursesto guide professional decisions and conduct. In 2017,she collaborated with colleagues in the development ofan online educational toolkit from the National HumanGenome Research Institute and is currently helpingestablish a global nursing alliance, G2NA. Both initiativesare intended to educate nursing professionals on how tointegrate genomic information into practice.Professor Badzek previously served at University of NorthCarolina Wilmington as Director of the School of Nursingand at West Virginia University, where she is an emeritusprofessor. Professor Badzek is a member of multipleorganisations, a recipient of national and internationalawards, and a fellow with several organisations includingthe National Academies of Practice, AACN WhartonLeadership Programme, and American Academy ofNursing.Dr. Suzanne H. CAMPBELLAssociate Professor, School of Nursing,The University of British Columbia, Vancouver, CanadaDr. Suzanne Campbell is Associate Professor (present)and previous Director (2012-2017) of the School ofNursing at the University of British Columbia, Vancouver,Canada. Her research programme examines the useof innovative teaching pedagogy, simulation, to teachclinical and non-technical skills such as women’s health,lactation, and health communication. Recently, she hasbeen developing and testing a scale to assess globalinterprofessional therapeutic communication evaluatingprovider patient interactions. Through texts, workshops,and conference proceedings she uses technology toempower faculty, students, and health care providersto incorporate creative, practical, and research-basedknowledge into pleasurable learning experiences. Herclinical focus is reproductive social justice through thepromotion and support of lactation and transition to newparenthood specifically for underserved populations. Sheconsults internationally on lactation, simulation, nursingand interprofessional education. She is a co-editor andco-author of AJN Book of the Year Awardee in Child HealthCore Curriculum for Interdisciplinary Lactation Care thatwill inform an international, evidence-based curriculumfor lactation consultants worldwide. Dr. Campbellparticipated in a Gates Foundation grant for Neo-BFHI inBrazil as part of the international research team. She isworking to promote interprofessional education, research,and practice at UBC, in British Columbia and globally.Professor Sally Chan is a global healthcare educator andresearcher. Her career influences the tripartite missionof research, education and practice. Supported by morethan 100 funded studies (more than Australian dollars7.5 million), more than 400 publications in internationalhealthcare journals and international presentations,Professor Chan has developed and sustainedinternational inter-institutional partnerships. The resultsof her sustained research agenda and scholarship havemade a recognised impact on healthcare practice andeducation in the Region.Professor Chan has been appointed by the World HealthOrganisation (WHO) to the Primary Care ConsultationGroup for Revision of ICD-10 Mental and BehaviouralDisorder. She is a member of the Council of Deans ofNursing & Midwifery, Australia & New Zealand. Herleadership is evident in her former appointment as chairof the East Asian Forum of Nursing Scholars (EAFONS);member of the Expert Group on Mental Health Servicesby the Hong Kong Government; and the National NursingTask Force by the Singapore Government.In 2013, Professor Chan has been awarded the‘International Nurse Researcher Hall of Fame’ by theSigma Theta Tau International Honours Society ofNursing and Fellow of the American Academy of Nursing.In 2016, she received the University of Newcastle ViceChancellor’s Award for International Engagement, andthe Faculty of Health and Medicine International Award forher exceptional achievement in building and sustaininginternational relations and engagement for the University.In 2017, she received the Outstanding Alumni Award fromthe Hong Kong Polytechnic University for her significantachievement and contribution to nursing developmentand Hong Kong community. In 2018, she received theOutstanding Achievement Award from the Hong KongCollege of Mental Health Nursing as well as the ResearchSupervision Excellence Award from School of Nursingand Midwifery, University of Newcastle.The First Cochrane Hong Kong Symposium 07

Plenary SpeakersPlenary SpeakersProfessor David R. THOMPSONProfessor Rintaro MORIDr. Chiehfeng CHENDirector, Cochrane TaiwanDirector, EBM Centre and Division of Plastic Surgery,Department of Surgery, Taipei Medical University WanFang Hospital, Taipei, TaiwanDr. Chiehfeng Chen is currently the Director of CochraneTaiwan, the Director of EBM Centre & Division of PlasticSurgery of Wan Fang Hospital, and a professor in TaipeiMedical University. As a pioneer in the development ofevidence-based medicine (EBM) in Taiwan, Dr. Chenestablished the first EBM Centre in northern Taiwan(located in Wan Fang Hospital) which has been active inproviding EBM training programmes for front-line healthprofessionals since 2001. During the past few years, heinitiated Chinese translation of several EBM textbooksto facilitate the adoption of EBM in broad allied healthsocieties. In addition, he serves as a reviewer providingEBM related comments and suggestions to medicalsocieties, and is involved in the development of manyclinical practice guidelines in Taiwan. With a particularinterest in medical informatics, he is striving to do researchon integrating real world evidence to clinical practice.08 The First Cochrane Hong Kong SymposiumProfessor Alexandra McCARTHYHead,School of Nursing, The University of Auckland, Auckland,New ZealandProfessor Alexandra McCarthy was appointed Head,School of Nursing, of the University of Auckland in April2017. She is also the Co-Director of the Women’s Wellnessafter Cancer Programme based at the Menzies Institute,Queensland, an Adjunct Professor at Griffith Universityand Visiting Fellow at Princess Alexandra Hospital,Brisbane. Prior to her relocation to Auckland, ProfessorMcCarthy was jointly appointed as the inaugural Chairof Cancer Nursing, Princess Alexandra Hospital and theSchool of Nursing, Queensland University of Technology.She has extensive practical experience in acute cancercare, which informs her strong international profile inclinical cancer research. Professor McCarthy’s researchhas two streams. The first focuses upon health promotionand risk reduction in long-term survivors of cancer withcomorbidities. The second focuses on the assessmentand management of the toxicities of acute cancertreatments, with an emphasis on the older cancer patient.Professor McCarthy has co-authored several well-citedsystematic reviews as part of her research programme.Regional Adviser (Population Ageing and SustainableDevelopment), Asia-Pacific Regional Office,United Nations Population FundVisiting Professor, Graduate School of Medicine,Kyoto University, Kyoto, JapanProfessor Rintaro Mori is the Regional Advisor onPopulation Ageing and Sustainable Development at theUnited Nations Population Fund (UNFPA) Asia-PacificOffice. After receiving paediatric training in Japan, hepracticed in Australia, Nepal and the UK as a seniorpaediatrician and studied epidemiology/public healthat the London School of Hygiene & Tropical Medicinebefore involving in guideline development for the NationalInstitute for Health and Care Excellence (NICE), UK.He has also been actively involved in research/aidworks in Madagascar, Bangladesh and Mongolia, aswell as research in health systems and women’s andchildren’s health at both national and global levels. Hewas appointed as Director of Department of Health Policyat the National Centre for Child Health and Developmentand Professor in Health Policy for Families and Children atKyoto University, where he has pursued his research onthe life-course approach to achieve sustainable social andhealth care systems in the context of population ageingsince 2012, before taking up his current role in 2018. He isalso the Editor of Cochrane Pregnancy and Childbirth andhas authored over 200 scientific publications.Professor of Nursing, School of Nursing and Midwifery,Queen’s University Belfast,Belfast, Northern Ireland, United KingdomProfessor David Thompson is Professor of Nursing,Queen’s University Belfast, in the UK. He is also ProfessorialFellow, the University of Melbourne; Adjunct Professor,Monash University; Honorary Professor, University ofQueensland and Distinguished Professor, Anhui MedicalUniversity. He has been Professor of Nursing and Director,Centre for the Heart and Mind, Australian CatholicUniversity and the University of Melbourne; Professor ofCardiovascular Nursing, University of Leicester; Directorand Professor of Nursing, the Chinese University of HongKong; Professor of Nursing, University of York; Professorof Nursing, University of Hull; and Professor of NursingResearch, UK Department of Health. He is editor of theEuropean Journal of Cardiovascular Nursing and anelected Fellow of the Royal College of Nursing, FlorenceNightingale Foundation, European Society of Cardiology,American Academy of Nursing and Cardiac Society ofAustralia and New Zealand.Professor Thompson is an acknowledged internationalleader in nursing and cardiovascular research, publishingover 600 papers, 15 books and 40 book chapters andsecuring research funding in excess of 40M. He has anh-index of 70 and over 22,000 citations. He is a foundingmember of the Cochrane Heart Group and conductssystematic reviews and meta-analyses in cardiovasculardisease prevention and rehabilitation.The First Cochrane Hong Kong Symposium 09

Round Table DiscussionSpeakersProfessor Yaolong CHENProfessor, Evidence Based Medicine Centre of LanzhouUniversity, Gansu, ChinaCo-Director, WHO Collaborating Centre for GuidelineImplementation and Knowledge TranslationChair, GIN AsiaDirector, Chinese GRADE CentreProfessor Yaolong Chen is a guideline methodologist at theEvidence Based Medicine Centre of Lanzhou University.He is the Founding Director of Chinese GRADE Centre andCo-Director of WHO Collaborating Centre for GuidelineImplementation and Knowledge Translation. He is alsothe Chair of GIN Asia (Guideline International Network).He received his Bachelor’s degree in clinical medicine atLanzhou University, Master’s degree in evidence-basedmedicine at Chinese Cochrane Centre, and PhD degreein integrative medicine at Lanzhou University. He studiedguideline development in McMaster University betweenSeptember 2010 and March 2011 as a visiting researchfellow and worked for the WHO Guidelines ReviewCommittee between September 2013 and March 2014 asa volunteer.Professor Chen is the Co-Founder and Co-Chair of RIGHT(Reporting Items for Practice Guidelines in Healthcare)working group, and the Co-Founder of Practice GuidelineRegister Platform (http://www.guidelines-registry.org).He has authored and co-authored more than 100 peerreviewed articles on evidence-based medicine, GRADEand practice guidelines. He has been invited to givenumerous presentations in Cochrane colloquiums,GIN conferences and other national and internationalsymposiums. He was involved in the development ofmore than 30 practice guidelines over the last five years.He is also the convener of the Testing Treatments EditorialAlliance (http://www.testingtreatments.org).10 The First Cochrane Hong Kong SymposiumRound Table DiscussionSpeakersProfessor Yingyao CHENProfessor of Health Services,Associate Dean, School of Public Health,Director, Key Lab of Health Technology Assessment,National Health Commission,Fudan University, Shanghai, ChinaDirector, WHO Collaborating Centre for HTA and ManagementProfessor Yingyao Chen is Professor of Health Servicesat the School of Public Health, Fudan University (FUSPH),Director of the Key Lab of Health Technology Assessment(National Health Commission) at Fudan University,and Director of WHO Collaborating Centre for HealthTechnology Assessment and Management. In addition,he is the Associate Dean of the School of Public Health,responsible for international collaborations.He received his Bachelor of Medicine and Master ofPublic Health at Shanghai Medical University in 1991and 1997 respectively, and his PhD in Management atFudan University in 2006. He took part in a visiting scholarprogramme at the University of California, Los Angelesfrom 1999 to 2001.His academic interests focus on health technologyassessment, health policy, health economics, andhospital management. He was a principal investigator ofseveral projects funded by the World Health Organisation(WHO), World Bank, China Medical Board, Ministry ofHealth, Ministry of Science and Technology, NationalNatural Science Foundation of China, and provincialhealth authorities. He has published 150 papers (140in Chinese and 10 in English) as the first author and/orcorresponding author. He is the Editor-in-chief of HealthServices Evaluation and Disease Burdens of Main BirthDefects and Economic Evaluation of Their PreventiveStrategies in China. He is also a co-author of 14 books.He serves as a member of board of directors of HealthTechnology Assessment international (HTAi) (20162019), the Vice-Chairman of the Public Health EconomicsCommittee affiliated to China Health EconomicsAssociation and the Vice-Chairman of Birth DefectsPrevention Committee affiliated to China Healthy BirthScience Association.Professor Jianping LIUProfessor Yan HUDean and Professor,School of Nursing, Fudan University, Shanghai, ChinaProfessor Yan Hu is the Dean of the School of Nursing atFudan University, Director of Fudan University Centre ofEvidence-Based Nursing and Shanghai Evidence-BasedNursing Centre, and Acting Chair of CMB China NursingNetwork (CCNN). She is also an editorial board memberof the Journal of the Association of Nurses in AIDS Care,International Journal of Nursing Practice and other peerreviewed nursing journals. In recent years, she hasreceived numerous research grants from National NaturalScience Foundation of China (NSFC), China MedicalBoard (CMB) and Shanghai Municipal Health Bureau, andhas published more than 200 papers in peer-reviewedinternational and national nursing journals.Professor Hu is a pioneer in promoting evidence-basednursing practice (EBNP) in China and other Asianregions. She led to establish the first EBNP Centrein mainland China in 2004. Her team has maintainedclose collaborations with international evidence-basedhealthcare institutes such as the Joanna Briggs Institute(JBI) and the Cochrane Collaboration, as well as nationalevidence-based medicine (EBM) institutes such asChinese EBM Centre and Chinese EBM Association.Her research focuses on implementation science andknowledge translation, and her team has successfullydeveloped several models and tools for evidence-basednursing practice. In addition, she is the Editor-in-chiefof several EBN textbooks (Chinese textbooks) and hasreceived two national awards for her outstanding researchwork on EBNP.Director,Centre for Evidence-Based Chinese Medicine, BeijingUniversity of Chinese Medicine, Beijing, ChinaProfessor Jianping Liu is a Professor of ClinicalEpidemiology and the Director of the Centre for EvidenceBased Chinese Medicine at the Beijing Universityof Chinese Medicine. He is an advisor for traditionalmedicine for the World Health Organisation (WHO),and a Chang Jiang Scholar named by the Ministry ofEducation, China. He is also a part-time senior researcherat the National Research Centre in Complementary andAlternative Medicine (NAFKAM) of the Arctic Universityof Norway, and an Adjunct Professor of Western SydneyUniversity in Australia. In addition, he is the currentPresident of the International Society for ComplementaryMedicine Research (ISCMR), a member of the CochraneComplementary Medicine Field Advisory Board, and pastChair of the Evidence-Based Medicine Committee underthe Chinese Association of Integrative Medicine. ProfessorLiu was awarded more than 30 grants from international,national and regional bodies for his research in TraditionalChinese Medicine and integrative medicine. He hasauthored 9 books, co-authored 8 books, and publishedmore than 520 papers in international and national peerreviewed journals.The First Cochrane Hong Kong Symposium 11

Workshop SpeakersRound Table DiscussionSpeakersProfessor Feng SUNAssociate Professor,Department of Epidemiology and Bio-statistics,School of Public Health, Peking University, Beijing, ChinaSecretary, Peking University Centre for Evidence BasedMedicine and Clinical ResearchSecretary, Centre of Post-marketing Safety Evaluation,Peking University Health Science CentreProfessor Feng Sun received her Bachelor’s degree fromHebei Medical University in 2003 and PhD degree fromPeking University in 2009. She was supported by ChinaScholarship Council (CSC) to visit Harvard University as avisiting scholar during 2016-2017. Her research interestsare in the field of pharmacoepidemiology and evidencebased medicine, in particular the use of new methodologyto conduct comparative effectiveness research. She haspublished widely in the areas of cardiovascular andendocrine epidemiology and medication safety.She is now responsible for a project (Developingmethodological guidance for evidence-based evaluationof cancer screening programmes in the Chinese settingand its application) funded by the National NaturalScience Foundation of China (NSFC). Her other projectsfocus on model development and evaluation in the field ofpharmacoepidemiology using big data based on hospitalor regional database, with the financial support fromNSFC and other grants.12 The First Cochrane Hong Kong SymposiumDr. Edwin S. Y. CHANProfessor Roman D. XUResearch Professor and Executive Deputy Director,Sun Yat-sen University Global Health Institute,School of Public Health and Institute of State Governance,Sun Yat-sen University, Guangdong, ChinaProfessor Roman Xu is the Executive Deputy Directorand Research Professor of the Sun Yat-sen Global HealthInstitute at the Sun Yat-sen University. His researchfocuses on health system innovations and implementationscience, particularly those involving chronic diseases,health quality, and mobile health in the context of globalhealth. He is currently leading a large-scale study onthe quality of primary health care in seven provinces inChina using unannounced standardised patients ands

decision-making through producing high quality and accessible systematic reviews and other synthesised research evidence. Cochrane evidence is internationally regarded as a powerful tool to enhance health care knowledge and practice. With the establishment of Cochrane Hong Kong, our School is committed to working hand in hand with other